Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial.
Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial.
García-Pavía, Cappelli + more
Open access
Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.